Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast cultures.

van Roozendaal, C E; Gillis, A J; Klijn, J G; van Ooijen, B; Claassen, C J; Eggermont, A M; Henzen-Logmans, S C; Oosterhuis, J W; Foekens, J A; Looijenga, L H

van Roozendaal, C E; Gillis, A J; Klijn, J G; van Ooijen, B; Claassen, C J; Eggermont, A M; Henzen-Logmans, S C; Oosterhuis, J W; Foekens, J A; Looijenga, L H.

Affiliation

van Roozendaal CE; Department of Medical Oncology, Daniel den Hoed Cancer Center/Academic Hospital, Rotterdam, The Netherlands.

FEBS Lett ; 437(1-2): 107-11, 1998 Oct 16.

Article in En | MEDLINE | ID: mdl-9804181

Subject(s)

Breast Neoplasms/genetics; Breast/metabolism; Genomic Imprinting; Insulin-Like Growth Factor II/metabolism; Muscle Proteins/metabolism; RNA, Untranslated; Cells, Cultured; Fibroblasts/metabolism; Humans; RNA, Long Noncoding; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Breast / Breast Neoplasms / Insulin-Like Growth Factor II / Genomic Imprinting / RNA, Untranslated / Muscle Proteins Limits: Humans Language: En Year: 1998 Type: Article

Search on Google

XML

PubMed Links